EUVIMEDEUVIMED entdecken
Crossref

METTL3‐Dependent YTHDF2 Mediates TSC1 Expression to Regulate Alveolar Epithelial Mesenchymal Transition and Promote Idiopathic Pulmonary Fibrosis

Min Liu, Yingying Sheng, Mengyu Li, Tianyu Pan, Wei Jiang, Yafei Zhang, Xin Pan, Cheng Huang, Jun Li iD, Yuanyuan Wang iD

Journal of Cellular Physiology · 2025-01 · 240 (1)

DOI: 10.1002/jcp.31473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 28.11.2024. Verfasst von Min Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Inflammation and Immune-Mediated Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical…. Hauptthemen laut MEDLINE: Tuberous Sclerosis Complex 1 Protein, Epithelial-Mesenchymal Transition, Idiopathic Pulmonary Fibrosis, RNA-Binding Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: This study was funded by the Natural Science Research Project of Anhui Educational Committee (2022AH050773); Bethune Charitable Foundation project (Z04JKM20210….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse, progressive interstitial lung disease with few treatment options and low survival rates is known as idiopathic pulmonary fibrosis (IPF). Alveolar epithelial cell damage and dysfunction are the main features of IPF. TSC1 has been documented to exert a pivotal function in governing cellular growth, proliferation, and ontogenesis. This work investigated TSC1's function and mechanism in IPF. Mice were given BLM to cause pulmonary fibrosis, and A549 cells underwent epithelial mesenchymal transition (EMT) in response to TGF‐β1. According to the data, TSC1 expression was reduced in IPF. Overexpression of TSC1 was established by adenopathy‐associated virus in vivo and adenovirus in vitro to significantly block the EMT process. Besides, the findings from the RNA‐sequencing analysis indicate that overexpression of TSC1 mitigated the EMT process by suppressing the activation of the AKT/mTOR pathway via downregulation of ACTN4 expression. To examine the upstream regulatory mechanism, we employed the SRAMP database to predict m 6 A modification of TSC1 mRNA, followed by verification of m 6 A modification levels and expression using MERIP‐qPCR, Dot blot, RT‐qPCR, and WB. The results indicated a high degree of m 6 A modification in TSC1 mRNA in pulmonary fibrosis. The expression of METTL3 was further found to be significantly elevated. METTL3 knockdown impeded EMT progression. METTL3 inhibits TSC1 expression by increasing TSC1 m 6 A modification through the reading protein YTHDF2. In conclusion, our study elucidated that the METTL3/YTHDF2/TSC1 signaling axis activates the AKT/mTOR pathway to promote the development of IPF. This study provides potential molecular‐level therapeutic targets for IPF disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberous Sclerosis Complex 1 ProteinEpithelial-Mesenchymal TransitionIdiopathic Pulmonary FibrosisRNA-Binding ProteinsAlveolar Epithelial CellsHumansAnimalsMiceA549 CellsProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine KinasesMaleMice, Inbred C57BLTransforming Growth Factor beta1Disease Models, AnimalMethyltransferases

Stichwörter der Autor:innen

AKT/mTOR pathwayEMTIPFMETTL3TSC1YTHDF2

Substanzen

Tuberous Sclerosis Complex 1 ProteinTSC1 protein, humanTsc1 protein, mouseMETTL3 protein, humanRNA-Binding ProteinsProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesTransforming Growth Factor beta1Methyltransferases

Autor:innen und Institutionen

  • Key Laboratory of Inflammation and Immune-Mediated Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province, China.
  • Department of Pharmacy, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China.

ORCID-Profile: Jun Li, Yuanyuan Wang

Förderung

  • This study was funded by the Natural Science Research Project of Anhui Educational Committee (2022AH050773); Bethune Charitable Foundation project (Z04JKM20210…

Zitieren

APA

Liu, M., Sheng, Y., Li, M., Pan, T., Jiang, W., Zhang, Y., Pan, X., Huang, C., Li, J., & Wang, Y. (2025). METTL3‐Dependent YTHDF2 Mediates TSC1 Expression to Regulate Alveolar Epithelial Mesenchymal Transition and Promote Idiopathic Pulmonary Fibrosis. Journal of Cellular Physiology, 240(1). https://doi.org/10.1002/jcp.31473

Vancouver

Liu M, Sheng Y, Li M, Pan T, Jiang W, Zhang Y, et al. METTL3‐Dependent YTHDF2 Mediates TSC1 Expression to Regulate Alveolar Epithelial Mesenchymal Transition and Promote Idiopathic Pulmonary Fibrosis. Journal of Cellular Physiology. 2025;240(1). doi:10.1002/jcp.31473

BibTeX
@article{Liu2025,
  author = {Liu, Min and Sheng, Yingying and Li, Mengyu and Pan, Tianyu and Jiang, Wei and Zhang, Yafei and Pan, Xin and Huang, Cheng and Li, Jun and Wang, Yuanyuan},
  title = {METTL3‐Dependent YTHDF2 Mediates TSC1 Expression to Regulate Alveolar Epithelial Mesenchymal Transition and Promote Idiopathic Pulmonary Fibrosis},
  journal = {Journal of Cellular Physiology},
  year = {2025},
  volume = {240},
  number = {1},
  doi = {10.1002/jcp.31473}
}
Kostenlos starten →